Early therapy with valaciclovir or famciclovir reduces but does not abrogate herpes simplex virus neuronal latency

Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb;19(1-2):461-70. doi: 10.1080/15257770008033021.

Abstract

Mice were infected via the ear pinna using a recombinant strain of HSV-1 expressing the beta-gal gene under the LAT promoter. Mice were treated continuously with valaciclovir or famciclovir, from 1 day before or 1 day after virus inoculation for 10 days. Ipsilateral and contralateral trigeminal and cervical ganglia were later assessed by co-cultivation or for X-Gal-positive or LAT-positive neurons. Latency was markedly reduced by early therapy, however, a basal level of HSV-1-positive neurons was detected in all mice.

MeSH terms

  • 2-Aminopurine / analogs & derivatives*
  • 2-Aminopurine / therapeutic use
  • Acyclovir / analogs & derivatives*
  • Acyclovir / therapeutic use
  • Animals
  • Antiviral Agents / therapeutic use*
  • Famciclovir
  • Herpes Simplex / drug therapy*
  • Herpes Simplex / virology
  • Humans
  • In Situ Hybridization
  • Mice
  • Mice, Inbred Strains
  • Neurons / virology*
  • Prodrugs / therapeutic use*
  • Simplexvirus / drug effects*
  • Simplexvirus / physiology
  • Trigeminal Ganglion / virology
  • Valacyclovir
  • Valine / analogs & derivatives*
  • Valine / therapeutic use
  • Virus Latency / drug effects*

Substances

  • Antiviral Agents
  • Prodrugs
  • 2-Aminopurine
  • Valine
  • Valacyclovir
  • Famciclovir
  • Acyclovir